These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 28258218)

  • 1. Structural analyses of
    Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
    J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.
    Warrilow AG; Hull CM; Parker JE; Garvey EP; Hoekstra WJ; Moore WR; Schotzinger RJ; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7121-7. PubMed ID: 25224009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
    Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
    Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
    Warrilow AG; Parker JE; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1352-60. PubMed ID: 23274672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
    Warrilow AG; Price CL; Parker JE; Rolley NJ; Smyrniotis CJ; Hughes DD; Thoss V; Nes WD; Kelly DE; Holman TR; Kelly SL
    Sci Rep; 2016 Jun; 6():27690. PubMed ID: 27291783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.
    Xiao L; Madison V; Chau AS; Loebenberg D; Palermo RE; McNicholas PM
    Antimicrob Agents Chemother; 2004 Feb; 48(2):568-74. PubMed ID: 14742211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.
    Podust LM; Poulos TL; Waterman MR
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3068-73. PubMed ID: 11248033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.
    Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J
    J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.
    Kudo M; Ohi M; Aoyama Y; Nitahara Y; Chung SK; Yoshida Y
    J Biochem; 2005 May; 137(5):625-32. PubMed ID: 15944416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
    Warrilow AG; Martel CM; Parker JE; Melo N; Lamb DC; Nes WD; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4235-45. PubMed ID: 20625155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents.
    Lamb DC; Kelly DE; Waterman MR; Stromstedt M; Rozman D; Kelly SL
    Yeast; 1999 Jun; 15(9):755-63. PubMed ID: 10398344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolution of Azole Resistance in
    Warrilow AG; Nishimoto AT; Parker JE; Price CL; Flowers SA; Kelly DE; Rogers PD; Kelly SL
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Wilson RK; Monk BC; Tyndall JD
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4982-9. PubMed ID: 26055382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
    Friggeri L; Hargrove TY; Wawrzak Z; Blobaum AL; Rachakonda G; Lindsley CW; Villalta F; Nes WD; Botta M; Guengerich FP; Lepesheva GI
    J Med Chem; 2018 Jul; 61(13):5679-5691. PubMed ID: 29894182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
    Keniya MV; Sabherwal M; Wilson RK; Woods MA; Sagatova AA; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
    Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
    ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
    Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
    J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.